Opaleye Management reports $29,593 Grace Therapeutics common share purchase
Opaleye Management, a 10% owner of Grace Therapeutics, reported open-market purchases of 14,632 common shares. Purchases were priced at USD 2.0175, USD 2.0446, USD 2.02 per share. Indirect beneficial ownership rose to 2,873,289 shares held through Opaleye, L.P. Disclaimer: This news brief was created by Public Technolo